Image‐guided diagnosis and treatment of glioblastoma
Authors:
Open Access
Abstract
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis and high recurrence rate. The presence of the blood–brain barrier (BBB) prevents diagnostic and therapeutic drugs from penetrating and working in GBM. In traditional surgical treatment, it is difficult to completely distinguish the boundary between tumor and surrounding normal tissue, resulting in incomplete resection of tumor. Therefore, the diagnosis and treatment of GBM are very challenging. Several molecular probes and nanoprobes have been reported to successfully penetrate the BBB, selectively target and accumulate in GBM to achieve in situ imaging of brain tumors, thus achieving accurate diagnosis and treatment of orthotopic or non‐orthotopic GBM. This paper reviews the advances of molecular probes and nanoprobes in image‐guided diagnosis and treatment of GBM. The design principle, application, and advantages of each probe are enumerated in detail. Finally, the prospects and potential challenges of probes in the diagnosis and treatment of GBM are discussed with a view to further promote the study and application of novel imaging probes in GBM.Keywords
Funding Information
- National Natural Science Foundation of China (22274005, U2067214, U2167222)
This publication has 143 references indexed in Scilit:
- Calpains mediate axonal cytoskeleton disintegration during Wallerian degenerationNeurobiology of Disease, 2013
- RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD TherapyMolecular Therapy, 2012
- A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticleNature Medicine, 2012
- Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1British Journal of Cancer, 2011
- Stabilization and functionalization of iron oxide nanoparticles for biomedical applicationsNanoscale, 2011
- Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 2011
- Hypoxia Increases the Dependence of Glioma Cells on GlutathioneJournal of Biological Chemistry, 2010
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- Correspondence re: Cecchin et al., Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients. Clin Cancer Res 2005;11:6901–7Clinical Cancer Research, 2006
- Quantification of, Visualization of, and Compensation for Brain Shift Using Intraoperative Magnetic Resonance ImagingNeurosurgery, 2000